Diagnosis requires a combination of clinical performance, imaging, laboratory testing, and pathology. The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Individualised development of treatment plans for treatment and management of large cell lung cancer, usually including drug treatment, rehabilitation, prevention, and regular follow-up, is required.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment to changes in the course of the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of large cell lung cancer.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.